Amundi
NEO icon

Amundi’s NeoGenomics NEO Stock Holding History

Amundi’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Buy
36,162
+15,039
+71% +$145K ﹤0.01% 1631
2026
Q1 		$157K Buy
+21,123
New +$222K ﹤0.01% 1916
2025
Q2 		– Sell
-110
Closed -$959 – 2001
2025
Q1 		$959 Buy
110
+63
+134% +$787 ﹤0.01% 2041
2024
Q4 		$875 Buy
+47
New +$730 ﹤0.01% 2040
2024
Q1 		– Sell
-4,802
Closed -$77.4K – 2050
2023
Q4 		$77.4K Hold
4,802
– – ﹤0.01% 1826
2023
Q3 		$60K Hold
4,802
– – ﹤0.01% 1844
2023
Q2 		$75.8K Hold
4,802
– – ﹤0.01% 1830
2023
Q1 		$71.1K Sell
4,802
-3,860
-45% -$55K ﹤0.01% 1819
2022
Q4 		$91K Sell
8,662
-3,023
-26% -$28.2K ﹤0.01% 1627
2022
Q3 		$107K Hold
11,685
– – ﹤0.01% 1545
2022
Q2 		$97K Buy
+11,685
New +$112K ﹤0.01% 1450

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Amundi's NEO Position: Q2 2026 in Review

Amundi increased its NeoGenomics (NEO) stake by 71% in Q2 2026, buying an estimated $145K and bringing the position to 36,162 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

Amundi first reported a position in NEO in Q2 2022 and has held it in 11 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Amundi held 36,162 shares of NeoGenomics worth $528K as of Q2 2026.
  • Amundi bought 15,039 NeoGenomics shares in Q2 2026, an estimated $145K.
  • NeoGenomics made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1631 holding.
  • Amundi first reported a position in NeoGenomics in Q2 2022 and has held it in 11 quarters since.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.